Mobile Application for IBD Patients With Biologics

A Mobile Application Guiding Patients With Inflammatory Bowel Disease During Biologic Treatment

Monitoring of biologic treatment in patients with inflammatory bowel disease (IBD) is important given the increased risk of infections. In this study we aim to evaluate the use of a mobile application to guide IBD patients and facilitate the monitoring of biologic treatment.

Biologic treatment can induce and maintain remission in patients with inflammatory bowel disease (IBD). However, biologics are associated with increased risk of infections. Therefore, it is important to regularly monitor patients during the course of therapy. This process can be time consuming for patients as well as clinicians. Mobile applications, have the potential to guide patients and facilitate monitoring of biologic treatment. In this study we aim to evaluate the use of a mobile application to guide IBD patients during biologic treatment. Adult patients with diagnosis of IBD treated with biologics will be included. The mobile application with personalised content will give patients information about their treatment, reminders for example when blood tests and questionnaires to check for adverse events.

Inclusion Criteria:

• Diagnosis of inflammatory bowel disease
• Treatment with infliximab or vedolizumab
• Ability to read and understand Dutch language

Exclusion Criteria:

• Patients recently started with biologic treatment